We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.6%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$8.89B
AUM Growth
+$1.45B
Cap. Flow
+$1.09B
Cap. Flow %
12.29%
Top 10 Hldgs %
26.12%
Holding
266
New
39
Increased
114
Reduced
52
Closed
27

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$63.8M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$50M
3
VR
Validus Hold Ltd
VR
+$44.1M
4
PBYI icon
Puma Biotechnology
PBYI
+$33.5M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$30.4M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.3M
2
DHR icon
Danaher
DHR
+$44.2M
3
HOLX
Hologic
HOLX
+$42M
4
BDX icon
Becton Dickinson
BDX
+$40.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$38.7M

Sector Composition

Rank Sector Weight
1 Financials 21.97%
2 Healthcare 21.33%
3 Technology 19.13%
4 Communication Services 9.13%
5 Industrials 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIVN icon
101
FIVE9
FIVN
$1.77B
$28.4M 0.32%
1,188,173
+238,901
+25% +$5.18M
FCX icon
102
Freeport-McMoran
FCX
$90B
$28.3M 0.32%
2,018,059
+32,558
+2% +$457K
FIS icon
103
Fidelity National Information Services
FIS
$21.5B
$27.8M 0.31%
297,270
– –
MIME
104
DELISTED
Mimecast Limited
MIME
$27.7M 0.31%
974,204
+101,851
+12% +$2.8M
NTES icon
105
NetEase
NTES
$76.5B
$27.7M 0.31%
524,275
– –
AGCO icon
106
AGCO
AGCO
$8.78B
$27.4M 0.31%
371,657
-102,152
-22% -$7.16M
XYZ
107
Block Inc
XYZ
$45.9B
$27.4M 0.31%
950,661
+126,462
+15% +$3.31M
TXN icon
108
Texas Instruments
TXN
$255B
$27.4M 0.31%
305,216
+64,100
+27% +$5.27M
TVTY
109
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$27.1M 0.3%
+663,100
New +$25.7M
RNG icon
110
RingCentral
RNG
$4.05B
$25.8M 0.29%
618,250
-27,623
-4% -$1.06M
EVBG
111
DELISTED
Everbridge, Inc. Common Stock
EVBG
$25.4M 0.29%
961,976
+25,000
+3% +$585K
STE icon
112
Steris
STE
$20.9B
$25.3M 0.28%
286,384
+86,384
+43% +$7.32M
CCL icon
113
Carnival Corporation Ltd
CCL
$36.1B
$24.9M 0.28%
386,074
– –
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$11.5B
$24.8M 0.28%
266,711
+22,500
+9% +$1.99M
AXDX
115
DELISTED
Accelerate Diagnostics
AXDX
$23.3M 0.26%
103,767
+23,270
+29% +$5.72M
ICUI icon
116
ICU Medical
ICUI
$3.93B
$23.2M 0.26%
125,006
+53,980
+76% +$9.41M
OMCL icon
117
Omnicell
OMCL
$1.86B
$22.6M 0.25%
443,481
+106,962
+32% +$5.12M
AXON
118
Axon Enterprise
AXON
$40.5B
$22M 0.25%
970,563
-135,312
-12% -$3.17M
PEGA icon
119
Pegasystems
PEGA
$4.41B
$21.9M 0.25%
761,372
-18,600
-2% -$538K
SAVE
120
DELISTED
Spirit Airlines, Inc.
SAVE
$21.2M 0.24%
+634,942
New +$25.4M
CYBR
121
DELISTED
CyberArk
CYBR
$21M 0.24%
513,394
-340,324
-40% -$14.4M
QVCGA
122
DELISTED
QVC Group Inc Series A
QVCGA
$20.8M 0.23%
18,152
– –
MDSO
123
DELISTED
Medidata Solutions, Inc.
MDSO
$20.5M 0.23%
262,226
-59,770
-19% -$4.55M
EGHT icon
124
8x8 Inc
EGHT
$247M
$20.3M 0.23%
1,503,376
-95,254
-6% -$1.3M
TDOC icon
125
Teladoc Health
TDOC
$1.58B
$20.3M 0.23%
+611,500
New +$20M
3 4
5
6 7

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Polar Capital held 266 positions worth $8.89B, up 20% from $7.43B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Polar Capital deployed $1.09B of net new capital in Q3 2017, opening 39 new positions and adding to 114 existing holdings. Its largest new stake was Puma Biotechnology: 360,000 shares worth $43.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Medtronic, an estimated $59.3M trimmed.

  • Polar Capital's largest Q3 2017 buy was Puma Biotechnology: 360,000 shares worth $43.1M.
  • Polar Capital added most to Amgen in Q3 2017, an estimated $63.8M increase.
  • Polar Capital's biggest Q3 2017 reduction was Medtronic, cutting an estimated $59.3M.
  • Polar Capital fully exited Hologic in Q3 2017, selling an estimated $42M.
  • Polar Capital's ten largest holdings make up 26% of its $8.89B portfolio in Q3 2017.
  • Polar Capital opened 39 new positions and closed 27 in Q3 2017.
  • Polar Capital's portfolio value rose 20% quarter-over-quarter to $8.89B.

Based on Polar Capital's 13F filing for Q3 2017, filed 14 Nov 2017.